doi: 10.3109/10731198309118804.
A new non-thrombogenic surface prepared by selective covalent binding of heparin via a modified reducing terminal residue
- PMID: 6667322
- DOI: 10.3109/10731198309118804
Item in Clipboard
A new non-thrombogenic surface prepared by selective covalent binding of heparin via a modified reducing terminal residue
Biomater Med Devices Artif Organs.
1983.
Abstract
A new method for the covalent binding of heparin to artificial surfaces has been developed. The heparinized surface releases insignificant amounts of heparin and can be regarded as stable. The blood contact properties as studied in vitro revealed that the surface was highly thromboresistant in terms of reduced platelet adhesion, surface catalyzed adsorption and inhibition of thrombin and capacity to prevent clotting of nonanticoagulated blood.
Similar articles
-
Fibrinogen adsorption, platelet adhesion and thrombin generation at heparinized surfaces exposed to flowing blood.Thromb Haemost. 2002 Apr;87(4):742-7. Thromb Haemost. 2002. PMID: 12008960
-
On the mechanism of coagulation inhibition on surfaces with end point immobilized heparin.Thromb Haemost. 1993 Aug 2;70(2):289-93. Thromb Haemost. 1993. PMID: 8236137
-
Covalently-bound heparin makes collagen thromboresistant.Arterioscler Thromb Vasc Biol. 2004 Mar;24(3):613-7. doi: 10.1161/01.ATV.0000116026.18945.66. Epub 2004 Jan 5. Arterioscler Thromb Vasc Biol. 2004. PMID: 14707039
-
Thrombogenicity of polysaccharide-coated surfaces.Biomaterials. 2003 May;24(11):1917-24. doi: 10.1016/s0142-9612(02)00620-8. Biomaterials. 2003. PMID: 12615482
-
Prevention of platelet adhesion and aggregation by a glutardialdehyde-stabilized heparin surface.Thromb Haemost. 1977 Apr 30;37(2):274-82. Thromb Haemost. 1977. PMID: 577629
Cited by
-
Durable endothelium-mimicking coating for surface bioengineering cardiovascular stents.Bioact Mater. 2021 May 24;6(12):4786-4800. doi: 10.1016/j.bioactmat.2021.05.009. eCollection 2021 Dec. Bioact Mater. 2021. PMID: 34095629 Free PMC article.
-
Enhancing Hemocompatibility in ECMO Systems With a Fibrinolytic Interactive Coating: in Vitro Evaluation of Blood Clot Lysis Using a 3D Microfluidic Model.Macromol Biosci. 2025 May;25(5):e2400530. doi: 10.1002/mabi.202400530. Epub 2025 Jan 13. Macromol Biosci. 2025. PMID: 39803823 Free PMC article.
-
Addressing the Inflammatory Response to Clinically Relevant Polymers by Manipulating the Host Response Using ITIM Domain-Containing Receptors.Polymers (Basel). 2014 Sep 29;6(10):2526-2551. doi: 10.3390/polym6102526. Polymers (Basel). 2014. PMID: 25705515 Free PMC article.
-
In vitro and in vivo study of sustained nitric oxide release coating using diazeniumdiolate-oped poly(vinyl chloride) matrix with poly(lactide-co-glycolide) additive.J Mater Chem B. 2013 Aug 7;1(29):3578-3587. doi: 10.1039/C3TB20277A. J Mater Chem B. 2013. PMID: 23914297 Free PMC article.
-
Pulmonary and haemodynamic effects of extracorporeal circulation in the cat and the beneficial effects of prostacyclin.Intensive Care Med. 1992;18(2):118-22. doi: 10.1007/BF01705045. Intensive Care Med. 1992. PMID: 1613191
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical